High levels of fatty acids or lipid metabolites, especially oxidized low-density lipoprotein, can activate CD36+ cells and at the same time reversely inhibit insulin-associated glucose transporter-4, thereby inducing insulin resistance, which is defined as obesity-associated insulin resistance [38, 39]. This evidence concerns the gene CD36 and Insulin resistance.